Metronidazole hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for metronidazole hydrochloride and what is the scope of patent protection?
Metronidazole hydrochloride
is the generic ingredient in two branded drugs marketed by Pfizer and Abraxis Pharm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for metronidazole hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Clinical Trials: | 589 |
| Patent Applications: | 2,990 |
| DailyMed Link: | metronidazole hydrochloride at DailyMed |
Recent Clinical Trials for metronidazole hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universitt Luzern | PHASE4 |
| Faiz ur rahman | NA |
| Stanford University | EARLY_PHASE1 |
Anatomical Therapeutic Chemical (ATC) Classes for metronidazole hydrochloride
US Patents and Regulatory Information for metronidazole hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | FLAGYL I.V. | metronidazole hydrochloride | INJECTABLE;INJECTION | 018353-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abraxis Pharm | METRONIDAZOLE HYDROCHLORIDE | metronidazole hydrochloride | INJECTABLE;INJECTION | 070295-001 | Oct 15, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
